Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Brothier is a French pharmaceutical company specializing in the development and manufacture of calcium alginate-based products for hemostasis and wound healing. Founded in 1949, the company has established itself as a leader in the use of seaweed-derived polymers to treat acute and chronic wounds, as well as epistaxis. Their flagship products, such as Coalgan and Algostéril, utilize the ion-exchange properties of calcium alginate to accelerate clotting and promote tissue regeneration. Brothier maintains a strong focus on research and development to expand the applications of their biopolymer technology across various surgical and dermatological fields. The company operates its own manufacturing facilities in France, ensuring high-quality standards for its global distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brothier.